\-\ Texto\\:\\ \ \(0\)\
\-\ left\\ frontal\\ lobe\\ biopsy\\:\\ \\ \\ spongioform\\ encephalopathy\\ consistent\\ with\\ creutzfeldt\\-jacob\\ disease\\.\ \(0\)\
\-\ brain\\ mri\\ scans\\ approximately\\ 6\\ months\\ apart\\ show\\ progressive\\ diffuse\\ cortical\\ atrophy\\,\\ t2\\/flair\\ and\\ diffusion\\ increased\\ signal\\ within\\ the\\ basal\\ ganglia\\.\\ \\ mild\\ increased\\ diffusion\\ signal\\ is\\ seen\\ in\\ the\\ posterior\\ thalamus\\ \\(pulvinar\\)\ \(0\)\
\-\ correspoding\\ relatively\\ decreased\\ adc\\ map\\ basal\\ ganglia\\ signal\\.\ \(0\)\
\-\ mr\\ spectroscopy\\ demonstrated\\ a\\ decrease\\ in\\ naa\\ peak\\.\ \(0\)\
\-\ spongioform\\ encephalopathy\\,\\ presumed\\ variant\\ creutzfeldt\\-jacob\\ disease\ \(0\)\
\-\ cruetzfeldt\\-jacob\\ disease\ \(0\)\
\-\ variant\\ creutzfeldt\\-jacob\\ disease\ \(0\)\
\-\ other\\ transmissible\\ spongioform\\ encephalopathies\ \(0\)\
\-\ diffuse\\ ischemic\\ insult\ \(0\)\
\-\ less\\ likely\\:\ \(2\)\
\-\ methanol\\ \\-\\ putamen\ \(0\)\
\-\ carbon\\ monoxide\\ \\-\\ globus\\ pallidus\\ \ \(0\)\
\-\ deposition\\ of\\ iron\\ or\\ copper\ \(0\)\
\-\ neoplastic\\ infiltration\\â\\€\\”particularly\\ of\\ lymphoma\\ or\\ glioma\\.\ \(0\)\
\-\ 25\\ y\\/o\\ with\\ new\\ onset\\ progrssive\\ dementia\\,\\ myclonus\\,\\ eeg\\ abnormalities\\,\\ history\\ of\\ eating\\ raw\\ sheep\\'s\\ brain\\ approximately\\ 2\\ years\\ ago\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ spongioform\\:\\ 0\\.3398280290914685\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.16150099814966784\ \(0\)\
\-\ ganglia\\:\\ 0\\.14409349818813766\ \(0\)\
\-\ variant\\:\\ 0\\.13605089686647995\ \(0\)\
\-\ basal\\:\\ 0\\.13118937518060472\ \(0\)\
\-\ signal\\:\\ 0\\.13036345062165208\ \(0\)\
\-\ diffusion\\:\\ 0\\.12914242444962049\ \(0\)\
\-\ disease\\:\\ 0\\.12871097767581618\ \(0\)\
\-\ correspoding\\:\\ 0\\.12259069440039014\ \(0\)\
\-\ progrssive\\:\\ 0\\.12259069440039014\ \(0\)\
\-\ myclonus\\:\\ 0\\.12259069440039014\ \(0\)\
\-\ sheep\\:\\ 0\\.12259069440039014\ \(0\)\
\-\ pulvinar\\:\\ 0\\.1171419531429573\ \(0\)\
\-\ transmissible\\:\\ 0\\.11327600969715616\ \(0\)\
\-\ encephalopathies\\:\\ 0\\.11327600969715616\ \(0\)\
\-\ raw\\:\\ 0\\.11327600969715616\ \(0\)\
\-\ copper\\:\\ 0\\.10782726843972332\ \(0\)\
\-\ naa\\:\\ 0\\.10575575315458555\ \(0\)\
\-\ methanol\\:\\ 0\\.10396132499392219\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.09968186432361933\ \(0\)\
\-\ pallidus\\:\\ 0\\.09968186432361933\ \(0\)\
\-\ approximately\\:\\ 0\\.09782506857756214\ \(0\)\
\-\ apart\\:\\ 0\\.09644106845135156\ \(0\)\
\-\ insult\\:\\ 0\\.09644106845135156\ \(0\)\
\-\ diffuse\\:\\ 0\\.0961464335490366\ \(0\)\
\-\ brain\\:\\ 0\\.09557512413925384\ \(0\)\
\-\ putamen\\:\\ 0\\.09551392503550077\ \(0\)\
\-\ monoxide\\:\\ 0\\.09551392503550077\ \(0\)\
\-\ globus\\:\\ 0\\.09383195150119229\ \(0\)\
\-\ carbon\\:\\ 0\\.0923372736737044\ \(0\)\
\-\ eeg\\:\\ 0\\.09164798158969964\ \(0\)\
\-\ dementia\\:\\ 0\\.08976982574740869\ \(0\)\
\-\ thalamus\\:\\ 0\\.08864932288871107\ \(0\)\
\-\ map\\:\\ 0\\.08712638374811758\ \(0\)\
\-\ iron\\:\\ 0\\.0845172667979583\ \(0\)\
\-\ increased\\:\\ 0\\.0829045579191573\ \(0\)\
\-\ eating\\:\\ 0\\.082673523905149\ \(0\)\
\-\ adc\\:\\ 0\\.07906852554052546\ \(0\)\
\-\ peak\\:\\ 0\\.07855160606416327\ \(0\)\
\-\ presumed\\:\\ 0\\.07830041651838966\ \(0\)\
\-\ deposition\\:\\ 0\\.07734013313647395\ \(0\)\
\-\ atrophy\\:\\ 0\\.07252389682994347\ \(0\)\
\-\ neoplastic\\:\\ 0\\.07085145059091445\ \(0\)\
\-\ ischemic\\:\\ 0\\.0677957291739137\ \(0\)\
\-\ scans\\:\\ 0\\.06670258618098626\ \(0\)\
\-\ decrease\\:\\ 0\\.06588789739149034\ \(0\)\
\-\ glioma\\:\\ 0\\.06511978836935454\ \(0\)\
\-\ relatively\\:\\ 0\\.062423125510683394\ \(0\)\
\-\ progressive\\:\\ 0\\.058710763730006\ \(0\)\
\-\ ago\\:\\ 0\\.056088024630247625\ \(0\)\
\-\ abnormalities\\:\\ 0\\.05552801654164613\ \(0\)\
\-\ cortical\\:\\ 0\\.05503440263907195\ \(0\)\
\-\ 25\\:\\ 0\\.05430551509513611\ \(0\)\
\-\ biopsy\\:\\ 0\\.05373358838098278\ \(0\)\
\-\ or\\:\\ 0\\.053334977055822734\ \(0\)\
\-\ new\\:\\ 0\\.05303230321324687\ \(0\)\
\-\ less\\:\\ 0\\.05215079056935106\ \(0\)\
\-\ mr\\:\\ 0\\.04960035602435953\ \(0\)\
\-\ frontal\\:\\ 0\\.0493382800153943\ \(0\)\
\-\ onset\\:\\ 0\\.04922342248345792\ \(0\)\
\-\ show\\:\\ 0\\.04866341439485643\ \(0\)\
\-\ decreased\\:\\ 0\\.04748271158057995\ \(0\)\
\-\ demonstrated\\:\\ 0\\.04711112340547227\ \(0\)\
\-\ years\\:\\ 0\\.046989509458466\ \(0\)\
\-\ likely\\:\\ 0\\.04580812779043833\ \(0\)\
\-\ lymphoma\\:\\ 0\\.045653790169449704\ \(0\)\
\-\ of\\:\\ 0\\.04500410970765898\ \(0\)\
\-\ months\\:\\ 0\\.04462038045664963\ \(0\)\
\-\ lobe\\:\\ 0\\.04429945178519636\ \(0\)\
\-\ mild\\:\\ 0\\.04345448354055069\ \(0\)\
\-\ consistent\\:\\ 0\\.04156500310287437\ \(0\)\
\-\ other\\:\\ 0\\.0398090364792211\ \(0\)\
\-\ posterior\\:\\ 0\\.039639822288369084\ \(0\)\
\-\ mri\\:\\ 0\\.039348729691622446\ \(0\)\
\-\ in\\:\\ 0\\.03813938050121055\ \(0\)\
\-\ seen\\:\\ 0\\.0360893368726417\ \(0\)\
\-\ within\\:\\ 0\\.035305695753415654\ \(0\)\
\-\ the\\:\\ 0\\.03059156430853997\ \(0\)\
\-\ with\\:\\ 0\\.03002066643499028\ \(0\)\
\-\ history\\:\\ 0\\.029287283467848833\ \(0\)\
\-\ left\\:\\ 0\\.02614926007066935\ \(0\)\
\-\ is\\:\\ 0\\.020992948321097542\ \(0\)\
\-\ and\\:\\ 0\\.015840161170947085\ \(0\)\
